Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Participate in Jefferies Global Healthcare Conference

Tuesday, November 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions will participate in the Jefferies Global Healthcare Conference in London from November 16-19, 2026. The company's senior management will present via webcast on November 18 from 8:00am to 8:25am UTC/GMT. A replay of the presentation will be accessible for approximately three months.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions will present at a major healthcare conference.
  • The event provides visibility for the company's management.
  • A replay of the presentation will be available for three months.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
COVID-HIG
Phase 1 · SARS-CoV-2 Infection

Full Press Release Details

GAITHERSBURG, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the Jefferies Global Healthcare Conference in London, November 16-19, 2026. Management will present via webcast on November 18 at 8:00am – 8:25am UTC/GMT (3:00am ET). A replay of the presentation will be available on the webcast page linked above for approximately three months. Visit Emergent’s Investor Relations page to learn more.

Frequently Asked Questions

When will Emergent BioSolutions present?

The presentation is scheduled for November 18, 2026.

Where is the Jefferies Global Healthcare Conference held?

The conference will take place in London.

How long will the presentation replay be available?

The replay will be available for approximately three months.

What time is Emergent's presentation?

The presentation is from 8:00am to 8:25am UTC/GMT.

ShareAdd on Google
Tags: EBS Emergent BioSolutions Jefferies Conference healthcare presentation investor relations
Last updated: Nov 10, 2026

Biotech snapshot

Cash runway
$176M liquidity · $0M/mo burn
Low dilution risk
Lead asset
COVID-HIGPhase 1
SARS-CoV-2 Infection →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →